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ABSTRACT
Vervet monkeys (Cercopithecus aethiops) were inoculated with two different strains of T. brucei gambiense 
in order to determine their clinical effects. Both strains of parasite behaved alike in the monkeys, producing a 
virulent disease course resulting in their death 10 to 15 weeks post-infection (PI). Clinical features exhibited in 
the monkeys included pyrexia, progressive mass loss, mild anaemia, oedema of hind quarters and central nervous 
system (CNS), disturbances which did not occur until week 8 PI, corresponding to onset of late-stage sleeping 
sickness in man. Clinical changes in the late stage of the infection in monkeys included somnolence, ataxia and 
uncontrolled shaking of the head. A significant drop in the packed cell volume (PCV) and body mass occurred 
in the late stage of the disease. It was concluded that a relationship exists between CNS pathology, PCV and 
mass loss in Gambian trypanosomosis. The course of infection observed in the monkeys also suggests that many 
strains of T. b. gambiense may be more virulent in both man and animals than has hitherto been known.
Key words: gambian trypanosomosis, monkeys
Introduction
Human African trypanosomosis (HAT, sleeping sickness) is a complex and debilitating 
disease in man. This disease still ravages several parts of sub-Saharan Africa despite decades 
of efforts aimed at its control (ANONYM., 1998; JANNIN, 2000; KABAYO, 2002). Human 
trypanosomosis now presents an emerging public health crisis in several countries, including 
Nigeria (AIRAUHI et al., 2001; WAISWA et al., 2003). The disease has been identified as a 
major health risk to tourists travelling to tropical Africa (SABBAH et al., 1997; CONWAY-
KLAASSEN et al., 2002; JELINEK et al., 2002).
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In West and Central Africa, HAT is caused by Trypanosoma brucei gambiense, 
transmitted principally by tsetse flies, Glossina palpalis and G. tachinoides resulting in a 
devastating, chronic form of the disease described as Gambian trypanosomosis (SCOTT, 
1970). Two stages of the disease are recognized: the early or haematolymphatic stage, 
and the late or meningoencephalic stage which is characterised by CNS disturbances 
(POLTERA, 1985; ANONYM., 1998). The trypanosomes of man and animals are generally 
characterized by haematological and biochemical aberrations, the severity of which are 
often determined by the level of parasitaemia, species of infecting trypanosome and host 
species (POLTERA, 1985; ANOSA, 1988).
Conflicting reports of observations in animal modes have posed an obstacle to the 
proper understanding of the factors associated with the pathogenesis of the Gambian form 
of HAT and chemotherapy and clinical management of the disease in man. Pigs (NKININ et 
al., 2002; WAISWA et al., 2003) are known animal reservoir hosts, while other animals such 
as dogs (GIBSON et al., 1978), sheep (MOLYNEUX, 1973), cattle (MEHLITZ et al., 1982), 
and monkeys and baboons (KAGERUKA et al., 1991) are also readily infected by T. brucei 
gambiense. Model studies involving T. brucei have been attempted in sheep (BOUTEILLE 
et al., 1988a, BOUTEILLE et al., 1988b) and mice (KEITA et al., 1997).
In this study we describe clinical changes and disease course precipitated by T. b. 
gambiense in vervet monkeys (Cercopithecus aethiops).
Materials and methods
A total of four vervet monkeys with an average body mass of 2.8 ± 0.8 kg were used in 
the study. The monkeys were acclimatized for a period of six months before use and were 
fed cooked beans, bananas, pawpaw leaves and pawpaw fruits, while water was provided 
ad libitum. All animals gained mass during the acclimatization period. Two monkeys 
were randomly selected and inoculated with NITR/Abraka strain of Trypanosoma brucei 
gambiense, while the remaining animals were inoculated with IL3250 strain. Both strains 
of parasites were obtained from patients suffering from sleeping sickness. A total of 2×106 
parasites were used to infect each of the monkeys intraperitoneally, while pre-infection 
data collection for four weeks served as control for each animal. 
The daily body temperature of the monkeys was taken using a clinical thermometer. 
Temperature was taken orally for monkey numbers 01, 02 and 03, while for monkey 
No 04 this could only be achieved via the rectum. The body mass of the monkeys was 
measured weekly using a weighing balance (Henson®, Gallenkamp, England). To determine 
parasitaemia after infection, wet blood film made daily from the ear vein was examined 
by light microscopy. Blood for determination of PCV and reticulocyte count was obtained 
through venipuncture of the femoral vein. The site for venipuncture was aseptically prepared 
by shaving and cleaning with 70% ethanol. In order to obtain blood for haematology or 
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mass determination, the monkeys were put under general anaesthesia by injecting ketamine 
hydrochloride (Parke-Davies, England) at a dose of 10.0mg/kg intramuscularly. PCV and 
reticulocyte counts were determined as described by DACIE and LEWIS (1984). During 
the course of infection a daily physical examination of the monkeys was undertaken. 
Analysis of variance (ANOVA) was used for statistical interpretation to determine level 
of significance.
Results
After infection, both strains of T. b. gambiense behaved similarly in the monkeys and 
they were therefore treated as one group.
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Monkeys became parasitaemic 3 to 4 days post-infection (PI). Parasitaemia was first 
recorded on day three in monkeys numbers 01, 02 and 04, while the remaining monkeys 
became positive by day four. Following parasitaemia, the animals exhibited fluctuating 
pyrexia, anorexia, intermittent diarrhoea, progressive emaciation and pale mucous 
membranes of the eyes. One monkey showed oedema of the hind legs and scrotum. Later, 
from week 8 PI, the primates became more emaciated, extremely dull and sleepy, while 
monkeys numbers 01 and 02 developed CNS disturbances characterized by unsteady gait 
and uncontrolled shaking of the head, corresponding to late-stage symptoms in man. By 
weeks 10 and 12 PI, monkeys numbers 02 and 01 died, respectively. At weeks 11 and 
13 the animals became too weak to be put under general anaesthesia for bleeding. The 
remaining monkeys developed CNS signs at week 12 PI and were euthanized at sternal 
recumbency by week 15 PI.
Changes in mean body mass, PCV and reticulocyte counts of the monkeys are 
summarized in Table 1. Average body mass of monkeys before infection was 3.73 ± 1.4 
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kg. After infection, the animals showed no significant change in body mass until week 12 
PI, when mass fell to 1.2 ± 1.4 kg, and then to 2.00 ± 0.0 by week 14 PI. The pre-infection 
PCV of the monkeys was 41.06 ± 0.6%. After infection, the PCV showed fluctuating 
decrease in the first seven weeks of infection, with the highest decrease to 32.7 7.7% by 
week 4 PI. From the eighth week the drop in PCV became progressively marked, with 
values ranging from 32.2 ± 2.6% from week 8 PI to 22.0 ± 2.8% by week 15 PI (Fig. 1. 
P≤0.05). The reticulocyte counts of the monkeys was 0.3 ± 0.0 pre-infection but increased 
progressively after infection, attaining maximum increase of 6.3 ± 1.0% (Fig. 1. P≤0.05) 
by the fifteenth week.
Discussion
Trypanosoma brucei gambiense showed marked pathogenicity in vervet monkeys 
resulting in death 10 to 15 weeks PI. This does not agree with the typically chronic nature 
of the disease in man (SCOTT, 1970; ANONYM, 1998) and previous observations on the 
course of T. b. gambiense experimental infection in monkeys and baboons (GODFREY and 
KILLICK-KENDRICK, 1967; YESUFU, 1971). YESUFU (1971) observed that vervet monkeys 
infected with T. b. gambiense looked apparently healthy and added mass one year after 
infection, although parasites could still be detected in the blood. Similarly, chimpanzees 
infected with T. b. gambiense achieved self-cure (YESUFU, 1971). However, the findings 
in this study are closer to the observations of MOLYNEUX (1973) in which T. b. gambiense 
resulted in an acute disease leading to death of monkeys 45 days post-infection. Although 
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Fig. 1. Changes in mean PCV and reticulocyte values of monkeys infected with T. brucei 
gambiense
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T. b. gambiense typically causes chronic disease, while T. b. rhodesiense causes acute 
disease in man, both acute forms of Gambian sleeping sickness and chronic forms of 
Rhodesian sleeping sickness do occur (APTED, 1970; SCOTT, 1970). The virulence of T. b. 
gambiense in vervet monkeys observed here probably arose from the high antigenic nature 
of the parasite strains. A virulent course of sleeping sickness following an outbreak of the 
disease in Abraka endemic focus, Delta State of Nigeria, has been described (EDEGHERE 
et al., 1989; ENWEZOR and UKAH, 2000; AIRAUHI et al., 2001).
The sequence of clinical disease observed in the monkeys was, however, similar to those 
observed in man (WELLDE et al., 1989a;  ANONYM., 1998). The CNS signs characterized 
by uncontrolled shaking of head and somnolence, which did not occur until weeks 8 to 12 
PI, correspond to the late stage of the disease in man (POLTERA, 1985; ANONYM., 1998) 
following CNS invasion by trypanosomes. KEITA et al. (1997) demonstrated late stage disease 
in T. brucei-infected mice. Similar CNS signs were also described in T. brucei-infected 
goats (WELLDE et al., 1989c) and T. b. rhodesiense-infected cattle (WELLDE et al., 1989b) 
which included uncontrolled movement of the head, ataxia, circling, aimless wandering 
and convulsions. Both the early and late stages of clinical sleeping sickness were therefore 
observable in the vervet monkeys.
POLTERA (1985) described CNS histopathological changes associated with late HAT 
which included meningoencephalitis, destruction of neurons, microglial reaction, diffuse 
scattering of inflammatory cells in the neuropil, and demyelination.
Mild anaemia, characterized by a slight drop in PCV and accompanying reticulocytosis 
in the early stage of the disease in monkeys, was in consonance with the observation 
of EMERIBE and ANOSA (1991) in T. b. gambiense-infected rabbits and natural sleeping 
sickness in man (POLTERA, 1985).
However, in the late stage, the anaemia characterized by significant drop in PCV, and 
body mass of the monkeys, was more marked than that observed by EMERIBE and ANOSA 
(1991). WELLDE et al. (1989c) observed similar marked anaemia and mass loss in T. b. 
rhodesiense infected cattle with CNS disturbances, suggesting that there is a relationship 
between CNS pathology, PCV and mass loss in late-stage sleeping sickness.
Although anaemia is a consistent pathological feature of African trypanosomosis, it 
is relatively less prominent in man (POLTERA, 1985). Also, T. b. rhodesiense causes more 
severe anaemia in man than T. b. gambiense (POLTERA, 1985; ANOSA, 1988) due to acute 
fulminating parasitaemia in the Rhodesian disease. Similarly, anaemia in chimpanzees 
infected with T. b. rhodesiense was found to be more severe than those infected with T. b. 
gambiense (GODFREY and KILLICK-KENDRICK, 1967). To judge from the outcome of T. b. 
gambiense infection in vervet monkeys, the observations obtained here appeared to compare 
well with those arising from T. b. rhodesiense. Also, with the exception of somnolence, 
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clinical observations in T. gambiense-infected monkeys did not differ from those described 
in T. brucei-infected animals (LOSOS and IKEDE, 1972; POLTERA, 1985).
It is concluded that even though T. b. gambiense precipitated a virulent course resulting 
in the death of the monkeys 10 to 15 weeks post-infection, clinical signs mimicked those of 
natural Gambian trypanosomosis in man. This fact makes vervet monkeys suitable animal 
models for clinical and chemotherapeutic investigation into human African trypanosomosis. 
The outcome of infection in the primates suggests that many strains of T. b. gambiense 
may be more virulent in man than has hitherto been known.
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SAŽETAK
Zeleni zamorci (Cercopithecus aethiops) bili su invadirani s dva različita soja T. brucei gambiense u svrhu 
utvrđivanja kliničkih znakova bolesti. Oba soja parazita slično su se ponašala izazivajući teški oblik bolesti što je 
dovelo do smrti 10 do 15 tjedana poslije invazije (PI). Klinički znakovi očitovali su se povišenom temperaturom, 
progresivnim gubitkom težine, blagom anemijom, edemom stražnjih ekstremiteta i poremećajima središnjeg 
živčanog sustava (CNS), koji su se pojavili 8. tjedna poslije invazije, što nalikuje kasnom stadiju bolesti 
spavanja u ljudi. Kliničke promjene u kasnom stadiju invazije u majmuna očitovale su se pospanošću, ataksijom, 
nekontroliranim pokretima glave, a došlo je i do značajnog pada vrijednosti staničnog volumena (PCV) i gubitka 
težine. Može se zaključiti da postoji veza između promjena u središnjem živčanom sustavu, padu vrijednosti 
PCV i gubitku težine u gambijskoj tripanosomozi. Tijek bolesti u majmuna također pokazuje da mnogi sojevi T. 
brucei gambiense mogu biti virulentniji u čovjeka i životinja nego što se dosada mislilo.
Ključne riječi: gambijska tripanosomoza, majmuni
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